Libra Infusions Limited announced unaudited earnings results for the third quarter and nine months ended March 2018. For the quarter, the company’s LPS were BDT 12.13 against EPS of BDT 4.10 a year ago. For the nine months, the company’s LPS were BDT 12.65 against EPS of BDT 4.88 a year ago. NOCFPS was BDT 9.70 against BDT 6.66 a year ago. NAV per share was BDT 1,565.31 as on March 31, 2018 and BDT 1,580.47 as on March 31, 2017.